These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 11329777)
21. [Chemoradiotherapy for patients with advanced head and neck cancer]. Tsukuda M Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513 [TBL] [Abstract][Full Text] [Related]
22. Pretreatment with chemotherapy in patients with advanced head and neck cancer. Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947 [TBL] [Abstract][Full Text] [Related]
23. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Murdoch D Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639 [TBL] [Abstract][Full Text] [Related]
24. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662 [TBL] [Abstract][Full Text] [Related]
25. [Head and neck cancer]. Inuyama Y; Fukuda S; Fujii M Gan To Kagaku Ryoho; 1995 May; 22(6):732-8. PubMed ID: 7755381 [TBL] [Abstract][Full Text] [Related]
26. The role of chemotherapy in the curative treatment of head and neck cancer. Pfister DG; Shaha AR; Harrison LB Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092 [TBL] [Abstract][Full Text] [Related]
27. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck. Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320 [TBL] [Abstract][Full Text] [Related]
29. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H; Tsukuda M; Watai K Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160 [TBL] [Abstract][Full Text] [Related]
30. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)]. Tahara M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996 [TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis. Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128 [TBL] [Abstract][Full Text] [Related]
32. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Posner MR Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867 [TBL] [Abstract][Full Text] [Related]
33. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer]. Inuyama Y; Fukuda S; Horiuchi M Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113 [TBL] [Abstract][Full Text] [Related]
34. [Neoadjuvant chemotherapy of head and neck cancer]. Fujii M; Kawasaki K Gan To Kagaku Ryoho; 1991 Sep; 18(12):2083-9. PubMed ID: 1716091 [TBL] [Abstract][Full Text] [Related]
35. [Palliative antineoplastic chemotherapy of patients with head and neck tumors]. Kleemann D; Hingst V; Kramp B HNO; 1994 May; 42(5):275-9. PubMed ID: 7519592 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma. Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568 [TBL] [Abstract][Full Text] [Related]
38. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M; Taguchi T Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926 [TBL] [Abstract][Full Text] [Related]
39. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial. Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909 [TBL] [Abstract][Full Text] [Related]
40. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? Adelstein DJ; Leblanc M J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]